Global Vaccine Adjuvants Market Research Report 2023(Status and Outlook)

Global Vaccine Adjuvants Market Research Report 2023(Status and Outlook)



Report Overview

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

The top five global manufacturers of vaccine adjuvants are GSK, CSL Limited, Brenntag Biosector, Seppic and SPI Pharma, with a combined market share of about 70 per cent. Europe is the largest consumption place, with a consumption market share nearly 43% in 2019. Following Europe, North America is the second largest consumption place with the consumption market share of 30%.

The Global Vaccine Adjuvants Market Size was estimated at USD 762 million in 2022 and is projected to reach USD 1503.92 million by 2029, exhibiting a CAGR of 10.20% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Vaccine Adjuvants market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine Adjuvants Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine Adjuvants market in any manner.

Global Vaccine Adjuvants Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

SEPPIC

SDA BIO

Brenntag Biosector

SPI Pharma

MVP Laboratories

Tj Kaiwei

Novavax

Zhuoyue

Aphios

Market Segmentation (by Type)

Oral

Subcutaneous

Intramuscular

Others

Market Segmentation (by Application)

Electrical and Electronics

Automotive

Public Utilities

Communication

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Vaccine Adjuvants Market

Overview of the regional outlook of the Vaccine Adjuvants Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Vaccine Adjuvants
1.2 Key Market Segments
1.2.1 Vaccine Adjuvants Segment by Type
1.2.2 Vaccine Adjuvants Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Vaccine Adjuvants Market Overview
2.1 Global Market Overview
2.1.1 Global Vaccine Adjuvants Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Vaccine Adjuvants Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Vaccine Adjuvants Market Competitive Landscape
3.1 Global Vaccine Adjuvants Sales by Manufacturers (2018-2023)
3.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2018-2023)
3.3 Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine Adjuvants Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Vaccine Adjuvants Sales Sites, Area Served, Product Type
3.6 Vaccine Adjuvants Market Competitive Situation and Trends
3.6.1 Vaccine Adjuvants Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine Adjuvants Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Vaccine Adjuvants Industry Chain Analysis
4.1 Vaccine Adjuvants Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Vaccine Adjuvants Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Vaccine Adjuvants Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine Adjuvants Sales Market Share by Type (2018-2023)
6.3 Global Vaccine Adjuvants Market Size Market Share by Type (2018-2023)
6.4 Global Vaccine Adjuvants Price by Type (2018-2023)
7 Vaccine Adjuvants Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine Adjuvants Market Sales by Application (2018-2023)
7.3 Global Vaccine Adjuvants Market Size (M USD) by Application (2018-2023)
7.4 Global Vaccine Adjuvants Sales Growth Rate by Application (2018-2023)
8 Vaccine Adjuvants Market Segmentation by Region
8.1 Global Vaccine Adjuvants Sales by Region
8.1.1 Global Vaccine Adjuvants Sales by Region
8.1.2 Global Vaccine Adjuvants Sales Market Share by Region
8.2 North America
8.2.1 North America Vaccine Adjuvants Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaccine Adjuvants Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaccine Adjuvants Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaccine Adjuvants Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaccine Adjuvants Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 SEPPIC
9.1.1 SEPPIC Vaccine Adjuvants Basic Information
9.1.2 SEPPIC Vaccine Adjuvants Product Overview
9.1.3 SEPPIC Vaccine Adjuvants Product Market Performance
9.1.4 SEPPIC Business Overview
9.1.5 SEPPIC Vaccine Adjuvants SWOT Analysis
9.1.6 SEPPIC Recent Developments
9.2 SDA BIO
9.2.1 SDA BIO Vaccine Adjuvants Basic Information
9.2.2 SDA BIO Vaccine Adjuvants Product Overview
9.2.3 SDA BIO Vaccine Adjuvants Product Market Performance
9.2.4 SDA BIO Business Overview
9.2.5 SDA BIO Vaccine Adjuvants SWOT Analysis
9.2.6 SDA BIO Recent Developments
9.3 Brenntag Biosector
9.3.1 Brenntag Biosector Vaccine Adjuvants Basic Information
9.3.2 Brenntag Biosector Vaccine Adjuvants Product Overview
9.3.3 Brenntag Biosector Vaccine Adjuvants Product Market Performance
9.3.4 Brenntag Biosector Business Overview
9.3.5 Brenntag Biosector Vaccine Adjuvants SWOT Analysis
9.3.6 Brenntag Biosector Recent Developments
9.4 SPI Pharma
9.4.1 SPI Pharma Vaccine Adjuvants Basic Information
9.4.2 SPI Pharma Vaccine Adjuvants Product Overview
9.4.3 SPI Pharma Vaccine Adjuvants Product Market Performance
9.4.4 SPI Pharma Business Overview
9.4.5 SPI Pharma Vaccine Adjuvants SWOT Analysis
9.4.6 SPI Pharma Recent Developments
9.5 MVP Laboratories
9.5.1 MVP Laboratories Vaccine Adjuvants Basic Information
9.5.2 MVP Laboratories Vaccine Adjuvants Product Overview
9.5.3 MVP Laboratories Vaccine Adjuvants Product Market Performance
9.5.4 MVP Laboratories Business Overview
9.5.5 MVP Laboratories Vaccine Adjuvants SWOT Analysis
9.5.6 MVP Laboratories Recent Developments
9.6 Tj Kaiwei
9.6.1 Tj Kaiwei Vaccine Adjuvants Basic Information
9.6.2 Tj Kaiwei Vaccine Adjuvants Product Overview
9.6.3 Tj Kaiwei Vaccine Adjuvants Product Market Performance
9.6.4 Tj Kaiwei Business Overview
9.6.5 Tj Kaiwei Recent Developments
9.7 Novavax
9.7.1 Novavax Vaccine Adjuvants Basic Information
9.7.2 Novavax Vaccine Adjuvants Product Overview
9.7.3 Novavax Vaccine Adjuvants Product Market Performance
9.7.4 Novavax Business Overview
9.7.5 Novavax Recent Developments
9.8 Zhuoyue
9.8.1 Zhuoyue Vaccine Adjuvants Basic Information
9.8.2 Zhuoyue Vaccine Adjuvants Product Overview
9.8.3 Zhuoyue Vaccine Adjuvants Product Market Performance
9.8.4 Zhuoyue Business Overview
9.8.5 Zhuoyue Recent Developments
9.9 Aphios
9.9.1 Aphios Vaccine Adjuvants Basic Information
9.9.2 Aphios Vaccine Adjuvants Product Overview
9.9.3 Aphios Vaccine Adjuvants Product Market Performance
9.9.4 Aphios Business Overview
9.9.5 Aphios Recent Developments
10 Vaccine Adjuvants Market Forecast by Region
10.1 Global Vaccine Adjuvants Market Size Forecast
10.2 Global Vaccine Adjuvants Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vaccine Adjuvants Market Size Forecast by Country
10.2.3 Asia Pacific Vaccine Adjuvants Market Size Forecast by Region
10.2.4 South America Vaccine Adjuvants Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vaccine Adjuvants by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Vaccine Adjuvants Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Vaccine Adjuvants by Type (2024-2029)
11.1.2 Global Vaccine Adjuvants Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Vaccine Adjuvants by Type (2024-2029)
11.2 Global Vaccine Adjuvants Market Forecast by Application (2024-2029)
11.2.1 Global Vaccine Adjuvants Sales (K MT) Forecast by Application
11.2.2 Global Vaccine Adjuvants Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings